Dr. Capone is President of the PRRF. His primary role is developing PRRF’s strategic plan while making sure its program and operations support its mission on a daily basis. Dr. Capone is an internationally recognized clinician, surgeon and educator. He has authored or co-authored over 300 publications in peer-reviewed medical journals, book chapters, and publications from clinical trials. He is currently a Professor of Biomedical Sciences at Oakland University, and Professor at the European School for Advanced Studies in Ophthalmology, Lugano, Switzerland. Dr. Capone is recognized in particular as a surgical innovator. He also serves as Co-President of Associated Retinal Consultants (ARC), the leading academically-oriented private retina practice in the world, and has held a number of leadership positions in ophthalmology over the last 25 years. He completed his undergraduate and medical degrees at Brown University, his residency at the University of Pittsburgh, and fellowship at Emory University.

The original founder of Diversified Portfolios, Inc. in 1993, Bob has more than 25 years of experience helping families and individuals meet the challenges of investing to ensure a secure financial future. He served as president of the company until 2023. Diversified Portfolios, Inc. is a fee-only investment advisory firm, primary focused on retirement planning and investment management.

A graduate of University of Detroit High School, Albion College (Economics) and the University of Detroit (JD and MBA combined program), Bob is a CFA charter holder, an attorney and a member of the CFA Society of Detroit. Bob and his wife, Anne, have two great kids, Ellen and Daniel. Bob is recently retired and enjoys skiing, cycling and tennis.

Dr. Al-Shabrawey is an expert on the study of diabetic retinopathy, a major cause of blindness worldwide, and has published more than 65 refereed articles on the disease in the past 20 years. His research funding since 2007 has included major grants from the National Eye Institute and the American Heart Association, and he currently possesses an NIH R01 grant that extends to 2024. Dr. Al-Shabrawey has garnered both national and international recognition for his work, as evidenced by his frequent invitations to speak at the Association for Research in Vision and Ophthalmology (ARVO) and the International Society of Eye Research (ISER). His research area is perfect for stimulating future scientific collaboration with ERI basic science and clinical vision researchers. In addition, Dr. Al-Shabrawey has exhibited an impressive record of mentoring graduate students, postdoctoral fellows and medical students in his laboratory. He was appointed to Director of the Oakland University Eye Research Institute in August 2021.

Patrick J. Droste, M.S., M.D. graduated medical school from Wayne State University in 1980, completed his residency in ophthalmology at Henry Ford Hospital, and a fellowship in Pediatric ophthalmology at Indiana University. He returned to Michigan in 1987 to begin his practice in Grand Rapids, Michigan now known as Pediatric Ophthalmology, P.C. Dr. Droste is a Clinical Professor at Michigan State University College of Human Medicine in the Departments of Neurology, Ophthalmology, and Surgery as well as a Clinical Professor at Michigan State University College of Osteopathy in the department of Neurology and Ophthalmology. He has served as past president of the Michigan Society of Eye Surgeons and Physicians, and serves on many committees for county, state and national medical/ophthalmology societies. Dr. Droste has published numerous articles in peer review journals, presentations and courses, and lectured internationally. He actively participates in clinical research at the community level with our local hospitals, and at the national level as a principal investigator for Pediatric Eye Disease Investigator Group (PEDIG). Philanthropy has been an important focus throughout Dr. Droste’s career. He created the Visually Impaired Sports Day which has occurred annually since 2002 in sponsorship with Spectrum Health, was a charter board member of Project Access which provides free medical services to the disadvantaged in Kent County, has cared for indigent children of third world countries through Heal the Children, and was a charter member of the ROPARD Board.

Chuck Walls first came to Associated Retinal Consultants PC (ARC) in 2007 after his son, Collin, was diagnosed with X-Linked Juvenile Retinoschisis. He is passionate about treatment for this retinal disease, and wanted to do more, so he joined the VRRF Board in 2014. More recently he is excited to work with families who have children with retinal diseases as the Family Development Chair on the PRRF Board. Chuck is a retired US Army Lieutenant Colonel and a combat veteran aviator with multiple combat and peace keeping tours. Chuck is also an Experimental Test Pilot, and after his retirement in 2009, continues to serve the US Army as a Department of the Army Civilian working as the Chief, Engineering Design and Analysis and still flies as an Experimental Test Pilot conducting tests for the Aviation Applied Technology Directorate at Fort Eustis, VA.. LTC(R) Walls received a Bachelors degree in Aerospace Engineering from the United States Military Academy in 1989, and a Masters degree in Engineering Management from University of Central Florida in 2002, and a Masters degree in Computer Resources and Information Management from Webster University in 2002. Chuck, and his wife, Donna, also have experience as Co-Founders and Co-Directors of an educational non-profit 501(c)(3) foundation for 10 years.

Kay White is a community volunteer who began to work with ROPARD when she chaired its first fund-raisers, The Artful Garden". She joined the Board of ROPARD in 1996. Kay has been active in many organizations, including the DSO, American Heart, American Lung and especially Common Ground where she has answered the crisis line for 34 years and served 4 terms as Board Chair. Kay graduated from Colby College with a B.A. She is on the Advisory Board of The Art Experience and is a member of two garden clubs. She also loves to play tennis and is an avid gardener.

Stephanie passion is partnering with community leaders to ignite meaningful and impactful change for the mission’s they care about most. With over 20 years working for nonprofit organizations, Stephanie is the guiding force behind millions raised for local and national organizations. Stephanie has led the Hope for Vision Walk since 2019 and is now serving as Foundation Manager for PRRF. She is also the owner of a nonprofit consulting company, Guiding Force Consulting, LLC. Stephanie is a proud graduate of Davenport University with a Master’s of business Administration and currently serves on the board of Guiding Harbor.

Luisa Recchia's passion for adding value to people who add value to others finds herself at the Pediatric Retinal Research Foundation. For years, she has worked with both for profit and non-profit organizations. Growing up in a large extended family, the phrase "it takes a village to raise a child" brings a lot of meaning. If one child suffered, we were all impacted and all pitched in and rolled up our sleeve. Luisa and her husband Jim have three adult sons working hard to pass on family traditions. As an entrepreneur, Luisa works as a coach for business owners and leadership teams helping them get what they want from their business.

ヘザーは非営利業界で17年以上、さまざまな管理業務に携わってきた。情熱的で献身的、そして思慮深いアプローチでクライアントと接する。プロセスの合理化、クライアントの事務的ニーズの予測、PRRFチームの整理整頓とデータ管理を得意とする。また、アウトリーチイベントや業界会議でもヘザーを見かけることがある。ヘザーが同僚の生活に大きな変化をもたらしていないときは、夫と充実した時間を過ごしたり、暴れん坊の愛犬マレーと遊んだりしている。

In 1990 Michael T. Trese, MD, founded what is now known as the Pediatric Retinal Research Foundation.

Dr. Trese is widely considered the father of modern pediatric vitreoretinal surgery. In a career spanning more than 40 years, he has been credited with significant breakthroughs and has taught many of today’s leading pediatric retina specialists.

In the 1980s, he revolutionized pediatric vitreoretinal surgery with his concept of lens-sparing vitrectomy for the treatment of complex pediatric retinal detachment due to advanced retinopathy of prematurity (ROP). His techniques have also been applied to diseases such as familial exudative vitreoretinopathy, juvenile X-linked retinoschisis and Coats disease. He led the way to the first FDA-approved drug for pharmacologic vitreolysis.

In addition to his achievements as a medical doctor, his impact on families world-wide through the work of the Foundation is significant. He championed early translational research in the quest for cures, was instrumental in bringing to reality the only research lab dedicated solely to pediatric retinal research and provided hope to countless families. We will continue this work in honor of our Founder, friend and colleague.